Public health interventions require balancing innovation, safety and public trust. Discuss the role of scientific evaluation and pharmacovigilance in ensuring the effectiveness and

Introduction

Vaccination programmes are among the most cost-effective public health interventions, preventing millions of deaths annually. However, their success depends not only on innovation and rapid deployment but also on rigorous scientific evaluation and robust pharmacovigilance systems that ensure safety, efficacy, and public trust.

Role of Scientific Evaluation

1. Ensuring Safety and Efficacy

• Vaccines undergo pre-clinical studies followed by Phase I, II, and III clinical trials to establish safety and effectiveness.
• Scientific evaluation identifies optimal dosage, efficacy across age groups, and potential adverse effects.

2. Evidence-Based Regulatory Approval

• Regulatory bodies such as the Central Drugs Standard Control Organisation (CDSCO) assess scientific evidence before granting approval.
• Ensures that benefits outweigh risks.

3. Adapting to Emerging Variants and Diseases

• Continuous research helps update vaccines against evolving pathogens.
• Supports development of next-generation vaccines.

4. Building Public Confidence

• Transparent publication of clinical data enhances credibility and acceptance.

Role of Pharmacovigilance

1. Monitoring Adverse Events Following Immunisation (AEFI)

• Detects rare or long-term side effects not identified during clinical trials.
• Enables timely corrective actions.

2. Strengthening Vaccine Safety Systems

• India’s AEFI Surveillance Programme and Pharmacovigilance Programme of India (PvPI) monitor vaccine-related adverse events.
• Helps refine vaccination strategies and recommendations.

3. Maintaining Public Trust

• Transparent reporting and investigation of adverse events counter misinformation and vaccine hesitancy.
• Demonstrates accountability and responsiveness.

4. Supporting Policy Decisions

• Real-world evidence generated through pharmacovigilance informs booster doses, age eligibility, and risk-benefit assessments.

Challenges

• Under-reporting of adverse events.
• Spread of misinformation through digital platforms.
• Limited surveillance capacity in remote areas.
• Balancing rapid vaccine deployment during emergencies with rigorous safety oversight.

Value Addition

WHO Principle: Vaccine safety surveillance is essential to sustain confidence in immunisation programmes and maximize public health benefits.

Diagram

         Vaccination Programmes
                   │
      ┌────────────┼────────────┐
      │            │            │
 Scientific   Pharmacovigilance Public
 Evaluation                     Trust
      │            │            │
      └────────────┼────────────┘
                   │
       Safe & Effective Vaccines
                   │
          Better Public Health

Conclusion

The effectiveness of vaccination programmes rests on a delicate balance between innovation, safety, and public trust. Rigorous scientific evaluation ensures that vaccines are safe and effective, while pharmacovigilance provides continuous monitoring in real-world settings. Together, they form the foundation of credible and resilient immunisation systems capable of protecting public health.

Value Addition (Global Example): The rapid development of COVID-19 vaccines demonstrated that accelerated innovation can coexist with scientific rigor and post-market surveillance when supported by robust regulatory frameworks.